Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
Pharmacoeconomics
|
July 21, 2007
A stated preference binary choice experiment to explore NICE decision making
Paul Tappenden, John Brazier, Julie Ratcliffe, et al.
International Journal of Technology Assessment in Health Care
|
August 5, 2014
Identification and review of cost-effectiveness model parameters: a qualitative study
Eva Kaltenthaler, Munira Essat, Paul Tappenden, et al.
International Journal of Technology Assessment in Health Care
|
October 23, 2009
Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 3, 2009
A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach
Jason Madan, Andrew Rawdin, Matt Stevenson, et al.
Health Policy (Amsterdam, Netherlands)
|
April 5, 2008
Comparing methods for full versus single technology appraisal: a case study of docetaxel and paclitaxel for early breast cancer
Eva Kaltenthaler, Paul Tappenden, Andrew Booth, et al.
Pharmacoeconomics
|
August 6, 2024
Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling
Johanna Lister, Suzy Paisley, Christopher Carroll, et al.
Journal of Health Economics
|
April 10, 2010
Simulation sample sizes for Monte Carlo partial EVPI calculations
Jeremy E Oakley, Alan Brennan, Paul Tappenden, et al.
Plos One
|
September 14, 2023
A systematic review of whole disease models for informing healthcare resource allocation decisions
Huajie Jin, Paul Tappenden, Xiaoxiao Ling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Health Economics
|
May 7, 2014
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme
Miqdad Asaria, Susan Griffin, Richard Cookson, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
Pharmacoeconomics
|
July 21, 2007
A stated preference binary choice experiment to explore NICE decision making
Paul Tappenden, John Brazier, Julie Ratcliffe, et al.
International Journal of Technology Assessment in Health Care
|
August 5, 2014
Identification and review of cost-effectiveness model parameters: a qualitative study
Eva Kaltenthaler, Munira Essat, Paul Tappenden, et al.
International Journal of Technology Assessment in Health Care
|
October 23, 2009
Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 3, 2009
A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach
Jason Madan, Andrew Rawdin, Matt Stevenson, et al.
Health Policy (Amsterdam, Netherlands)
|
April 5, 2008
Comparing methods for full versus single technology appraisal: a case study of docetaxel and paclitaxel for early breast cancer
Eva Kaltenthaler, Paul Tappenden, Andrew Booth, et al.
Pharmacoeconomics
|
August 6, 2024
Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling
Johanna Lister, Suzy Paisley, Christopher Carroll, et al.
Journal of Health Economics
|
April 10, 2010
Simulation sample sizes for Monte Carlo partial EVPI calculations
Jeremy E Oakley, Alan Brennan, Paul Tappenden, et al.
Plos One
|
September 14, 2023
A systematic review of whole disease models for informing healthcare resource allocation decisions
Huajie Jin, Paul Tappenden, Xiaoxiao Ling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2012
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework
Paul Tappenden, Jim Chilcott, Alan Brennan, et al.
Health Economics
|
May 7, 2014
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme
Miqdad Asaria, Susan Griffin, Richard Cookson, et al.
Page
of 9